最新消息

Lee & Ko Attorneys Keum Nang Park of the Healthcare Group have been named to Benchmark Litigation Asia-Pacific’s ‘Top 100 Women in Litigation 2026’ in recognition of their outstanding achievements in healthcare-related patent and regulatory disputes, as well as major competition law matters.

Ms. Park serves as Co-Head of Lee & Ko’s Healthcare Group, advising clients on intellectual property matters—including pharmaceutical and biotechnology patents—as well as a broad range of regulatory matters involving the Ministry of Health and Welfare, the Ministry of Food and Drug Safety, and the Ministry of Environment. She brings deep and wide-ranging expertise across the healthcare industry, including pharmaceuticals, medical devices, cosmetics, food, dietary supplements and household chemical products. Ms. Park was named to this year’s list in recognition of her success in defending market exclusivity on behalf of the patent holder of a world-renowned cardiovascular blockbuster drug, prevailing in more than 100 patent suits brought by numerous generic manufacturers. Her selection also reflects her achievements in protecting patent rights in litigation involving a widely used blockbuster biologic for chronic inflammatory disease and a prominent blockbuster biologic for ophthalmic disease.

Benchmark Litigation, published by Delinian, formerly Euromoney, is a globally renowned publication focusing on dispute resolution and litigation. Its annual ‘Top 100 Women in Litigation’ list recognizes 100 leading female litigators in the Asia-Pacific region based on months of in-depth research and analysis.

韩国广场律师事务所在“2022年度亚太地区争议解决榜”的九个领域被评选为Tier1律师事务所。不仅如此，韩国广场律师事务所的23名律师也因在其专业领域的突出表现，分别被评选为“诉讼之星”及“未来之星”。

商业与交易  竞争与反垄断 建设  破产  知识产权  国际仲裁  劳动与就业  产品责任及召回  白领犯罪 

Euromoney发行的“争议解决榜”作为争议解决及诉讼法律领域的世界级专刊，每年都会根据各大律师事务所提交的资料，以及与律师、客户、诉讼专家等进行的访谈结果，通过深度分析，对外公布榜单。